Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Bladder (Urothelial, Transitional Cell) Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun-Yatsen Memorial Hospital, Guangzhou, Guangdong, China
Contact: Study coordinator (Daqin Wu, PhD) · wudq23@mail2.sysu.edu.cn · 020-52193348

Study leads

Tianxin Lin, Ph.D
Study Chair
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemoablation for Low-Grade Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer

Abroad (travel likely)RecruitingPHASE2

Vienna, Austria

MICROBIOTA AND BLADDER CANCER

Bladder (Urothelial, Transitional Cell) Cancer

Abroad (travel likely)Recruiting

Cannes, France · Marseille, France

Selecting Hypoxic Tumours for Treatment Modification

Bladder (Urothelial, Transitional Cell) Cancer · Prostate Cancer

Abroad (travel likely)Recruiting

Manchester, United Kingdom

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Bladder (Urothelial, Transitional Cell) Cancer · Bladder Cancer Recurrence · Progression of Bladder Cancer

Abroad (travel likely)Recruiting

Lanzhou, China